Cargando…

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology

[Image: see text] After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered c...

Descripción completa

Detalles Bibliográficos
Autores principales: Borsari, Chiara, Trader, Darci J., Tait, Annalisa, Costi, Maria P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997565/
https://www.ncbi.nlm.nih.gov/pubmed/32023055
http://dx.doi.org/10.1021/acs.jmedchem.9b01456
Descripción
Sumario:[Image: see text] After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.